Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Everest Medicines has raised $6.8M in total funding. The most recent round was Post-IPO Secondary. The last funding was announced in May 2026.
Everest Medicines's investors include RA Capital Management, Hillhouse Investment, Janus Henderson Investors, Decheng Capital, Pavilion Capital.
Everest Medicines is headquartered in New York, United States.
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Everest Medicines is at the Post-IPO Secondary stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Everest Medicines — Funding & Investors." VCBacked, May 14, 2026, https://www.vcbacked.co/company/everest-medicines. Accessed August 13, 2026.
VCBacked. (2026). Everest Medicines — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/everest-medicines
{{cite web |title=Everest Medicines — Funding & Investors |url=https://www.vcbacked.co/company/everest-medicines |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated